Literature DB >> 33232735

Epigenetic factors in atherosclerosis: DNA methylation, folic acid metabolism, and intestinal microbiota.

Huimin Hou1, Huiying Zhao2.   

Abstract

Atherosclerosis is a complex disease, influenced by both genetic and non-genetic factors. The most important epigenetic mechanism in the pathogenesis of atherosclerosis is DNA methylation, which involves modification of the gene without changes in the gene sequence. Nutrients involved in one-carbon metabolism interact to regulate DNA methylation, especially folic acid and B vitamins. Deficiencies in folic acid and other nutrients, such as vitamins B6 and B12, can increase homocysteine levels, induce endothelial dysfunction, and accelerate atherosclerotic pathological processes. Supplemented nutrients can improve DNA methylation status, reduce levels of inflammatory factors, and delay the process of atherosclerosis. In this review, the influence of intestinal flora on folate metabolism and epigenetics is also considered.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; DNA methylation; Epigenetics; Folic acid metabolism; Homocysteine; Intestinal microbiota

Mesh:

Substances:

Year:  2020        PMID: 33232735     DOI: 10.1016/j.cca.2020.11.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  DNA Methylation Aberrant in Atherosclerosis.

Authors:  Yao Dai; Danian Chen; Tingting Xu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

Review 2.  Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?

Authors:  Ana Clara Aprotosoaie; Alexandru-Dan Costache; Irina-Iuliana Costache
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

3.  The Relationship Between Serum Folate Level and Residual Renal Function in CAPD Patients.

Authors:  Jianpeng Yu; Qi Zhou; Ying Xu; Tieyun Wang; Jun Du; Lifang Zhao; Juan Li; Haiyan Wang; Qianqian Xu; Xueli Lai; Zhiyong Guo
Journal:  Int J Gen Med       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.